ACM
AVXL icon

Aquatic Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Aquatic Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,100
Closed -$25K – 1242
2023
Q2 		$25K Sell
3,100
-6,500
-68% -$55.7K ﹤0.01% 1095
2023
Q1 		$82K Buy
+9,600
New +$95.8K 0.01% 789
2022
Q4 		– Sell
-8,700
Closed -$90K – 1356
2022
Q3 		$90K Buy
+8,700
New +$91.8K 0.01% 783
2022
Q2 		– Sell
-1,200
Closed -$15K – 1193
2022
Q1 		$15K Buy
+1,200
New +$14.8K 0.02% 559

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Aquatic Capital Management's AVXL Position: Q3 2023 in Review

Aquatic Capital Management sold out of Anavex Life Sciences (AVXL) in Q3 2023, closing a stake of 3,100 shares — an estimated $25K sold.

Aquatic Capital Management first reported a position in AVXL in Q1 2022 and held it in 4 quarters. The position peaked at $90K in Q3 2022. 143 funds tracked by Wall St. Rank hold AVXL as of Q3 2023.

  • Aquatic Capital Management reported no remaining Anavex Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 3,100 Anavex Life Sciences shares in Q3 2023, an estimated $25K.
  • Aquatic Capital Management first reported a position in Anavex Life Sciences in Q1 2022 and held it in 4 quarters.
  • Aquatic Capital Management's Anavex Life Sciences position peaked at $90K in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2023.

Based on Aquatic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.